ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 67 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $804,000 | +1262.7% | 151,956 | +747.6% | 0.05% | +1225.0% |
Q4 2020 | $59,000 | -10.6% | 17,927 | -9.0% | 0.00% | 0.0% |
Q2 2020 | $66,000 | -86.1% | 19,692 | -77.6% | 0.00% | -85.2% |
Q1 2019 | $476,000 | +199.4% | 87,800 | +64.4% | 0.03% | +200.0% |
Q4 2018 | $159,000 | – | 53,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prentice Capital Management, LP | 390,381 | $1,292,000 | 0.49% |
ETF MANAGERS GROUP, LLC | 891,025 | $2,949,000 | 0.09% |
AdvisorShares Investments LLC | 353,009 | $1,168,000 | 0.06% |
ALGERT GLOBAL LLC | 51,028 | $169,000 | 0.05% |
Bernardo Wealth Planning LLC | 27,219 | $90,000 | 0.04% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 31,552 | $104,000 | 0.03% |
ZEKE CAPITAL ADVISORS, LLC | 49,700 | $165,000 | 0.02% |
Walleye Capital LLC | 51,554 | $171,000 | 0.02% |
Dynamic Technology Lab Private Ltd | 19,021 | $63,000 | 0.01% |
J.W. COLE ADVISORS, INC. | 37,064 | $123,000 | 0.01% |